Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...

The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

All three cannabinoids reduced the electrical activity linked to Nav1.8, but CBG had the strongest effect. This suggests that CBG could be the most promising candidate for developing new pain ...

The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

A doctor with NYU says this new pill is not addictive. A mother who lost her son from opioid addiction hopes for the best but wants to see if this new pill will truly be a safe alternative.

A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...

Emily Hernandez, a Missouri woman pardoned after her ties to the Jan. 6, 2021, insurrection at the U.S. Capitol, was ...